SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 74 filers reported holding SAGE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $314 | -54.2% | 15,278 | +4.8% | 0.00% | -60.0% |
Q2 2023 | $686 | -0.9% | 14,580 | -11.6% | 0.01% | 0.0% |
Q1 2023 | $692 | +12.9% | 16,494 | +2.6% | 0.01% | +25.0% |
Q4 2022 | $613 | -99.9% | 16,077 | -7.7% | 0.00% | -20.0% |
Q3 2022 | $682,000 | +148.9% | 17,414 | +105.3% | 0.01% | +150.0% |
Q2 2022 | $274,000 | -24.3% | 8,482 | -22.4% | 0.00% | 0.0% |
Q1 2022 | $362,000 | -16.8% | 10,927 | +6.8% | 0.00% | 0.0% |
Q4 2021 | $435,000 | +19.5% | 10,229 | +24.6% | 0.00% | 0.0% |
Q3 2021 | $364,000 | -6.7% | 8,210 | +19.7% | 0.00% | 0.0% |
Q2 2021 | $390,000 | -10.8% | 6,858 | +17.5% | 0.00% | 0.0% |
Q1 2021 | $437,000 | +5.8% | 5,839 | +22.3% | 0.00% | 0.0% |
Q4 2020 | $413,000 | -46.6% | 4,774 | -12.8% | 0.00% | -60.0% |
Q3 2018 | $774,000 | -46.8% | 5,477 | -41.0% | 0.01% | -44.4% |
Q2 2018 | $1,454,000 | -10.0% | 9,287 | -7.4% | 0.01% | -18.2% |
Q1 2018 | $1,615,000 | -26.4% | 10,028 | -24.7% | 0.01% | -26.7% |
Q4 2017 | $2,194,000 | +986.1% | 13,322 | +425.5% | 0.02% | +1400.0% |
Q2 2017 | $202,000 | +90.6% | 2,535 | -28.0% | 0.00% | 0.0% |
Q2 2016 | $106,000 | +29.3% | 3,522 | +38.2% | 0.00% | 0.0% |
Q1 2016 | $82,000 | +5.1% | 2,549 | +90.7% | 0.00% | 0.0% |
Q4 2015 | $78,000 | +6.8% | 1,337 | -22.8% | 0.00% | 0.0% |
Q3 2015 | $73,000 | +92.1% | 1,731 | +230.3% | 0.00% | – |
Q2 2015 | $38,000 | +280.0% | 524 | +168.7% | 0.00% | – |
Q1 2015 | $10,000 | +42.9% | 195 | 0.0% | 0.00% | – |
Q4 2014 | $7,000 | – | 195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |